Efficacy of TDCS for Treating Working Memory Dysfunction and Depression in Temporal Lobe Epilepsy
Efficacy of Transcranial Direct Current Stimulation for Treating Working Memory Dysfunction and Depression For Patients With Temporal Lobe Epilepsy
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Memory difficulty ranks among the most common complaints for patients with temporal lobe epilepsy. While these cognitive problems may affect quality of life more than seizure frequency, no effective therapy exists. Transcranial Direct Current Stimulation (tDCS) is a method of safe, noninvasive, and painless brain stimulation delivering low intensity direct current through scalp electrodes to modulate brain activity. Several recently published studies demonstrate the enhancement of working memory and mood with stimulation of the frontal region of the brain. Furthermore, tDCS has never been reported to have induced a seizure. The aim of our study is to determine whether real tDCS can improve memory function and mood. The investigators are enrolling patients with well-controlled temporal lobe epilepsy who have not undergone brain surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2012
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 2, 2014
CompletedFirst Posted
Study publicly available on registry
October 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedApril 15, 2016
April 1, 2016
3 years
October 2, 2014
April 13, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in EEG Power
Visits 1, 5, 6 & 7 over 5 weeks
Secondary Outcomes (1)
Cognitive Tests
Visits 1, 5, 6 & 7 over 5 weeks
Study Arms (2)
Transcranial Direct Current Stimulation
ACTIVE COMPARATORSubjects will receive a total of 5 sessions on consecutive days. During each session, 2 mA of tDCS will be applied for 20 minutes over the left DLPFC (active or sham). The electrodes will have the size of 35cm2 each. Direct current will be transferred by a saline-soaked pair of surface sponge electrodes and delivered b y a specially developed, battery driven, constant current stimulator with a maximum output of 2mA.
Sham TDCS
SHAM COMPARATORFor sham-controlled tDCS subjects, the same montage will be used; however current will be applied for only 30 seconds - this is a reliable method of sham stimulation as sensations arising from tDCS treatment occur only at the beginning of application as also demonstrated by a randomized study (Gandiga et al. 2006).
Interventions
Transcranial Direct Current Stimulation is administered but at 0mA
Eligibility Criteria
You may qualify if:
- age between 18-70 years
- diagnosis of temporal lobe epilepsy, with seizure focus defined by seizure semiology, EEG, MRI Brain, PET and/or ictal and interictal SPECT.
- Must have a stable seizure frequency in the two (2) months prior to enrollment, as verified by the patient's seizure log and/or clinic notes and without recent antiepileptic medication changes.
- Must score above 22/30 on the Montreal Cognitive Assessment (MoCA).
- Must be able to provide informed consent.
You may not qualify if:
- Patient has a progressive or unstable neurological or systemic disease
- Patient has an ictal focus over the F3 or F4 (DLPFC) field
- Patient has a history of severe depression, as determined by a screen inventory test such as the Beck Depression Inventory or a psychiatrist
- Patient has a history of severe traumatic brain injury or prior brain surgery with skull defect
- Contraindictations to tDCS, including metal in the head or implanted brain medical devices
- Pregnancy
- Any implanted electrical medical device, including pacers and implanted cardiac defibrillators
- History of schizophrenia, schizoaffective disorder, other psychosis, rapid-cycling bipolar illness, alcohol/drug abuse within the past year
- History of dementia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NYU Langone Healthlead
- Epilepsy Foundationcollaborator
- American Epilepsy Societycollaborator
- American Academy of Neurologycollaborator
Study Sites (1)
Neurology
New York, New York, 11106, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anli Liu, MD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2014
First Posted
October 20, 2014
Study Start
November 1, 2012
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
April 15, 2016
Record last verified: 2016-04